This report contains market size and forecasts of Antivenoms for Treating Spider Bites in global, including the following market information:
Global Antivenoms for Treating Spider Bites Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antivenoms for Treating Spider Bites Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Antivenoms for Treating Spider Bites companies in 2021 (%)
The global Antivenoms for Treating Spider Bites market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Polyvalent Anti-Venom Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antivenoms for Treating Spider Bites include CSL, Pfizer, Merck, BTG, Bharat Serums and Vaccines, Serum Biotech, MicroPharm, Haffkine Bio-Pharmaceutical and Rare Disease Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antivenoms for Treating Spider Bites manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antivenoms for Treating Spider Bites Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antivenoms for Treating Spider Bites Market Segment Percentages, by Type, 2021 (%)
Polyvalent Anti-Venom
Monovalent Anti-Venom
Global Antivenoms for Treating Spider Bites Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antivenoms for Treating Spider Bites Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Non-profit Institutions
Global Antivenoms for Treating Spider Bites Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antivenoms for Treating Spider Bites Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antivenoms for Treating Spider Bites revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antivenoms for Treating Spider Bites revenues share in global market, 2021 (%)
Key companies Antivenoms for Treating Spider Bites sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Antivenoms for Treating Spider Bites sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
CSL
Pfizer
Merck
BTG
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts